The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
Abstract
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTThe Medicinal Chemist's Toolbox: An Analysis of Reactions Used in the Pursuit of Drug CandidatesStephen D. Roughley*‡ and Allan M. Jordan§View Author Information‡ Vernalis (R&D) Ltd., Granta Park, Cambridge, CB21 6GB, U.K.§ Cancer Research UK Drug Discovery Unit, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester, M20 4BX, U.K.*Phone: (+44) 01223 895555. Fax: (+44) 01223 895556. E-mail: [email protected]Cite this: J. Med. Chem. 2011, 54, 10, 3451–3479Publication Date (Web):April 19, 2011Publication History Received18 February 2011Published online2 May 2011Published inissue 26 May 2011https://pubs.acs.org/doi/10.1021/jm200187yhttps://doi.org/10.1021/jm200187yreview-articleACS PublicationsCopyright © 2011 American Chemical SocietyRequest reuse permissionsArticle Views51874Altmetric-Citations2000LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-AlertscloseSupporting Info (1)»Supporting Information Supporting Information SUBJECTS:Alkyls,Amides,Amines,Aromatic compounds,Chemical reactions Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds
Miyaura, N., & Suzuki, A. (1995) · Chemical Reviews · doi:10.1021/cr00039a007 · Cited by 12,817
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Fluorine in medicinal chemistry
Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V. (2008) · Chem. Soc. Rev. · doi:10.1039/b610213c · Cited by 7,570
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Mitsunobu, O. (1981) · Synthesis · doi:10.1055/s-1981-29317 · Cited by 4,118
Understanding organofluorine chemistry. An introduction to the C–F bond
O'Hagan, D. (2008) · Chem. Soc. Rev. · doi:10.1039/b711844a · Cited by 4,045
Ertl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
Maryanoff, B. E., & Reitz, A. B. (1989) · Chemical Reviews · doi:10.1021/cr00094a007 · Cited by 2,605
The Properties of Known Drugs. 1. Molecular Frameworks
Bemis, G. W., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602928 · Cited by 2,482
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Biaryl Phosphane Ligands in Palladium‐Catalyzed Amination
Surry, D. S., & Buchwald, S. L. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800497 · Cited by 2,016
Analysis of the reactions used for the preparation of drug candidate molecules
Carey, J. S., Laffan, D., Thomson, C., & Williams, M. T. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b602413k · Cited by 1,915
Selected Patented Cross-Coupling Reaction Technologies
Corbet, J.-P., & Mignani, G. (2006) · Chemical Reviews · doi:10.1021/cr0505268 · Cited by 1,851
N-methoxy-n-methylamides as effective acylating agents
Nahm, S., & Weinreb, S. M. (1981) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)91316-4 · Cited by 1,798
Rational Development of Practical Catalysts for Aromatic Carbon−Nitrogen Bond Formation
Wolfe, J. P., Wagaw, S., Marcoux, J.-F., & Buchwald, S. L. (1998) · Accounts of Chemical Research · doi:10.1021/ar9600650 · Cited by 1,791
Amide bond formation and peptide coupling
Montalbetti, C. A. G. N., & Falque, V. (2005) · Tetrahedron · doi:10.1016/j.tet.2005.08.031 · Cited by 1,786
A Medicinal Chemist’s Guide to Molecular Interactions
Bissantz, C., Kuhn, B., & Stahl, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100112j · Cited by 1,731
Hartwig, J. F. (1998) · Angewandte Chemie International Edition · Cited by 1,719
Halogen bonds in biological molecules
Auffinger, P., Hays, F. A., Westhof, E., & Ho, P. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407607101 · Cited by 1,634
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Key green chemistry research areas—a perspective from pharmaceutical manufacturers
Constable, D. J. C., Dunn, P. J., Hayler, J. D., Humphrey, G. R., Leazer, Jr., Linderman, R. J., Lorenz, K., Manley, J., Pearlman, B. A., Wells, A., et al. (2007) · Green Chem. · doi:10.1039/b703488c · Cited by 1,554
Prediction of Physicochemical Parameters by Atomic Contributions
Wildman, S. A., & Crippen, G. M. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990307l · Cited by 1,464
Carbon–heteroatom bond formation catalysed by organometallic complexes
Hartwig, J. F. (2008) · Nature · doi:10.1038/nature07369 · Cited by 1,007
Greener Approaches to Organic Synthesis Using Microreactor Technology
Mason, B. P., Price, K. E., Steinbacher, J. L., Bogdan, A. R., & McQuade, D. T. (2007) · Chemical Reviews · doi:10.1021/cr050944c · Cited by 985
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
Physiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 946
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
Lipophilicity in drug discovery
Waring, M. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003605098 · Cited by 873
Recent development of peptide coupling reagents in organic synthesis
Han, S.-Y., & Kim, Y.-A. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.01.020 · Cited by 773
Redox Economy in Organic Synthesis
Burns, N. Z., Baran, P. S., & Hoffmann, R. W. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200806086 · Cited by 769
The direct catalytic asymmetric aldol reaction
Trost, B. M., & Brindle, C. S. (2010) · Chemical Society Reviews · doi:10.1039/b923537j · Cited by 750
Halogen atoms in the modern medicinal chemistry: hints for the drug design
Hernandes, M., Cavalcanti, S. M., Moreira, D. R., de Azevedo Junior, W., & Leite, A. C. (2010) · Current Drug Targets · doi:10.2174/138945010790711996 · Cited by 723
Protecting-group-free synthesis as an opportunity for invention
Young, I. S., & Baran, P. S. (2009) · Nature Chemistry · doi:10.1038/nchem.216 · Cited by 667
Aiming for the Ideal Synthesis
Gaich, T., & Baran, P. S. (2010) · The Journal of Organic Chemistry · doi:10.1021/jo1006812 · Cited by 647
The impact of microwave synthesis on drug discovery
Kappe, C. O., & Dallinger, D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1926 · Cited by 610
Halogen Bonding—A Novel Interaction for Rational Drug Design?
Lu, Y., Shi, T., Wang, Y., Yang, H., Yan, X., Luo, X., Jiang, H., & Zhu, W. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9000133 · Cited by 559
Total synthesis of marine natural products without using protecting groups
Baran, P. S., Maimone, T. J., & Richter, J. M. (2007) · Nature · doi:10.1038/nature05569 · Cited by 510
Palladium – A review of exposure and effects to human health
Kielhorn, J., Melber, C., Keller, D., & Mangelsdorf, I. (2002) · International Journal of Hygiene and Environmental Health · doi:10.1078/1438-4639-00180 · Cited by 471
Abdel-Magid, A. F., & Mehrman, S. J. (2006) · Organic Process Research & Development · doi:10.1021/op0601013 · Cited by 461
Ritchie, T. J., Macdonald, S. J. F., Young, R. J., & Pickett, S. D. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.11.014 · Cited by 442
Enantioselective direct aldol reaction: the blossoming of modern organocatalysis
Guillena, G., Nájera, C., & Ramón, D. J. (2007) · Tetrahedron: Asymmetry · doi:10.1016/j.tetasy.2007.09.025 · Cited by 426
Lessons Learned from Marketed and Investigational Prodrugs
Ettmayer, P., Amidon, G. L., Clement, B., & Testa, B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0303812 · Cited by 384
Modern Aldol Methods for the Total Synthesis of Polyketides
Schetter, B., & Mahrwald, R. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602780 · Cited by 378
Chemoselectivity: The Mother of Invention in Total Synthesis
Shenvi, R. A., O’Malley, D. P., & Baran, P. S. (2009) · Accounts of Chemical Research · doi:10.1021/ar800182r · Cited by 334
Heteroaromatic Rings of the Future
Pitt, W. R., Parry, D. M., Perry, B. G., & Groom, C. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801513z · Cited by 332
Advanced organic synthesis using microreactor technology
Ahmed-Omer, B., Brandt, J. C., & Wirth, T. (2007) · Org. Biomol. Chem. · doi:10.1039/b615072a · Cited by 320
Abdel‐Magid, A. F., & Mehrman, S. J. (2007) · ChemInform · doi:10.1002/chin.200703235 · Cited by 317
Studies in Classification Data Analysis and knowledge Organization
Vichi, M. (2008) · IRIS Research product catalog (Sapienza University of Rome) · Cited by 302
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901
Barrett, S. D., Bridges, A. J., Dudley, D. T., Saltiel, A. R., Fergus, J. H., Flamme, C. M., Delaney, A. M., Kaufman, M., LePage, S., Leopold, W. R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.054 · Cited by 289
Ertl, P., Jelfs, S., Mühlbacher, J., Schuffenhauer, A., & Selzer, P. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060217p · Cited by 254
de Ruiter, G., Tartakovsky, E., Oded, N., & van der Boom, M. E. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906382 · Cited by 229
The Rule of Five for Non-Oral Routes of Drug Delivery: Ophthalmic, Inhalation and Transdermal
Choy, Y. B., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0292-6 · Cited by 202
Compound lipophilicity for substrate binding to human P450s in drug metabolism
Lewis, D. F. V., Jacobs, M. N., & Dickins, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03115-0 · Cited by 172
Development of fluorination methods using continuous-flow microreactors
Baumann, M., Baxendale, I. R., Martin, L. J., & Ley, S. V. (2009) · Tetrahedron · doi:10.1016/j.tet.2009.05.083 · Cited by 163
A quantitative assessment of hERG liability as a function of lipophilicity
Waring, M. J., & Johnstone, C. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.061 · Cited by 159
Physicochemical drug properties associated within vivotoxicological outcomes: a review
Price, D. A., Blagg, J., Jones, L. H., Greene, N., & Wager, T. T. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903042318 · Cited by 155
Akritopoulou‐Zanze, I., & Hajduk, P. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.12.002 · Cited by 116
Gleeson, M. P., Bravi, G., Modi, S. P., & Lowe, D. M. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.002 · Cited by 111
The discovery of GSK221149A: A potent and selective oxytocin antagonist
Liddle, J., Allen, M. J., Borthwick, A. D., Brooks, D. P., Davies, D. E., Edwards, R. M., Exall, A. M., Hamlett, C. C. F., Irving, W. R., Mason, A. M., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.008 · Cited by 91
Reducing the Risk of Drug Attrition Associated with Physicochemical Properties
Leeson, P. D., & Empfield, J. R. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45024-1 · Cited by 85
Halogen–water–hydrogen bridges in biomolecules
Zhou, P., Lv, J. H., Zou, J., Tian, F., & Shang, Z. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2009.10.006 · Cited by 73
Knowledge-based chemoinformatic approaches to drug discovery
Ghose, A. K., Herbertz, T., Salvino, J. M., & Mallamo, J. P. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.012 · Cited by 72
From Structure Diagrams to Visual Chemical Patterns
Schomburg, K. T., Ehrlich, H., Stierand, K., & Rarey, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100209a · Cited by 70
Warmus, J. S., Flamme, C. M., Zhang, L. Y., Barrett, S. D., Bridges, A. J., Chen, H., Gowan, R. C., Kaufman, M. D., Sebolt-Leopold, J., Leopold, W. R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.015 · Cited by 68
Evaluation of a series of bicyclic CXCR2 antagonists
Walters, I. A. S., Austin, C. A., Austin, R. P., Bonnert, R. V., Cage, P. A., Christie, M. I., Ebden, M. R., Gardiner, S. D., Grahames, C., Hill, S., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.039 · Cited by 63
Clarke, B. P., Demont, E. H., Dingwall, C., Dunsdon, R. M., Faller, A., Hawkins, J., Hussain, I., MacPherson, D. T., Maile, G., Matico, R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.019 · Cited by 58
Walker, D. P., Bi, F. C., Kalgutkar, A. S. S., Bauman, J. N., Zhao, S. X., Soglia, J. R., Aspnes, G. E., Kung, D. W., Klug-McLeod, J. L., Zawistoski, M. P., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.030 · Cited by 57
Kinase Patent Space Visualization Using Chemical Replacements
Southall, N. T., & Ajay (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051201m · Cited by 56
Chen, Y. L., Braselton, J. P., Forman, J. T., Gallaschun, R. J., Mansbach, R. S., Schmidt, A. W., Seeger, T., Sprouse, J. S., Tingley, F. D., Winston, E., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070578k · Cited by 48
Tecle, H., Shao, J., Li, Y., Kothe, M., Kazmirski, S. L., Penzotti, J. E., Ding, Y., Ohren, J. F., Moshinsky, D., Coli, R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.108 · Cited by 45
Drug approvals and failures: implications for alliances
Czerepak, E. A., & Ryser, S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2531 · Cited by 45
Drug discovery chemistry: a primer for the non-specialist
Jordan, A. M., & Roughley, S. D. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.04.005 · Cited by 45
Self-citationXu, W., Gray, D. L., Glase, S. A., & Barta, N. S. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.007 · Cited by 33
Bromidge, S. M., Bertani, B., Borriello, M., Faedo, S., Gordon, L. J., Granci, E., Hill, M., Marshall, H. R., Stasi, L. P., Zucchelli, V., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.084 · Cited by 30
Structure and property based design of factor Xa inhibitors: Pyrrolidin-2-ones with biaryl P4 motifs
Young, R. J., Borthwick, A. D., Brown, D., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.023 · Cited by 29
Fish, P. V., Deur, C., Gan, X., Greene, K. L., Hoople, D. W. T., MacKenny, M., Para, K. S., Reeves, K. A., Ryckmans, T., Stiff, C. M., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.050 · Cited by 29
Whitlock, G. A., Fish, P. V., Fray, M. J., Stobie, A., & Wakenhut, F. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.082 · Cited by 29
Jäckel, H., & Klein, W. (1991) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19910100304 · Cited by 26
Deaton, D. N., Gao, E. N., Graham, K. P., Gross, J. W., Miller, A. B., & Strelow, J. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.048 · Cited by 25
Whitlock, G. A., Blagg, J., & Fish, P. V. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.080 · Cited by 24
Young, R. J., Borthwick, A. D., Brown, D., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.019 · Cited by 23
The Role of Fluorine in the Discovery and Optimization of CNS Agents
Hodgetts, K. J., Combs, K. J., Elder, A. M., & Harriman, G. C. B. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45026-5 · Cited by 21
Valuation benefits of structure-enabled drug discovery
Borshell, N., Papp, T., & Congreve, M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3392 · Cited by 21
Barlaam, B. C., Ballard, P. G., Bradbury, R. H., Ducray, R., Germain, H., Hickinson, D. M., Hudson, K., Kettle, J. G., Klinowska, T. C. M., Magnien, F., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.052 · Cited by 18
Deaton, D. N., Graham, K. P., Gross, J. W., & Miller, A. B. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.046 · Cited by 16
Mente, S., Gallaschun, R., Schmidt, A., Lebel, L., Vanase-Frawley, M., & Fliri, A. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.028 · Cited by 8
Cited by
The Hitchhiker’s Guide to Flow Chemistry
Plutschack, M. B., Pieber, B., Gilmore, K., & Seeberger, P. H. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00183 · Cited by 1,995
Contribution of Organofluorine Compounds to Pharmaceuticals
Inoue, M., Sumii, Y., & Shibata, N. (2020) · ACS Omega · doi:10.1021/acsomega.0c00830 · Cited by 1,944
Schneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910
Rethinking drug design in the artificial intelligence era
Schneider, P., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0050-3 · Cited by 894
Large-Scale Applications of Amide Coupling Reagents for the Synthesis of Pharmaceuticals
Dunetz, J. R., Magano, J., & Weisenburger, G. A. (2016) · Organic Process Research & Development · doi:10.1021/op500305s · Cited by 819
Metadata
- Authors
- Roughley, S. D., & Jordan, A. M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-05-02
- Volume
- 54
- Issue
- 10
- Pages
- 3451-3479
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1969487950
- Cited by
- 2,725
- References
- 88
- FWCI
- 70.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.